CYTOSORBENTS CORPORATION
CYTOSORBENTS CORPORATION is a registered legal entity registered in United States under 5629349, and its current status with Delaware Division of Corporations is active. The company was incorporated on 10 April 2016 and lists its registered address as United States. 5 shareholders are on record for CYTOSORBENTS CORPORATION, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for CYTOSORBENTS CORPORATION, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Skylands Capital, LLC, holding 10.4% — the largest recorded stake — followed by CM Management, LLC at 8.3%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 6 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Skylands Capital, LLC | 10.4% | Delaware Division of Corporations | |
| CM Management, LLC | 8.3% | Delaware Division of Corporations | |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7.1% | Delaware Division of Corporations | |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Berman Intrinsic Value Fund | 3.7% | Delaware Division of Corporations | |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Berman Intrinsic Value Fund | 3.6% | Delaware Division of Corporations |
Officers
5
The Ceo & Director of CYTOSORBENTS CORPORATION currently on record is Phillip P. Chan M.d., Ph.d.; five officers are currently on record for CYTOSORBENTS CORPORATION, filed with Delaware Division of Corporations.
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at CYTOSORBENTS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
CYTOSORBENTS CORPORATION has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
CYTOSORBENTS CORPORATION
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CYTOSORBENTS CORPORATION?
Five shareholders are currently on record for CYTOSORBENTS CORPORATION, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Skylands Capital, LLC, holding 10.4% — the largest recorded stake — followed by CM Management, LLC at 8.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CYTOSORBENTS CORPORATION's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CYTOSORBENTS CORPORATION is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CYTOSORBENTS CORPORATION have on record?
5 shareholders are shown on record for CYTOSORBENTS CORPORATION. The register reports 6 in total; only the top 5 by holding are shown here.
What is CYTOSORBENTS CORPORATION's company registration number?
CYTOSORBENTS CORPORATION's registration number is 5629349, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is CYTOSORBENTS CORPORATION still an active company?
CYTOSORBENTS CORPORATION's status on Delaware Division of Corporations is listed as active.
When was CYTOSORBENTS CORPORATION incorporated?
CYTOSORBENTS CORPORATION was incorporated on 10 April 2016, according to Delaware Division of Corporations.
What is CYTOSORBENTS CORPORATION's registered address?
The registered address on file for CYTOSORBENTS CORPORATION is United States.
Who are the officers/directors of CYTOSORBENTS CORPORATION?
The Ceo & Director of CYTOSORBENTS CORPORATION currently on record is Phillip P. Chan M.d., Ph.d.; five officers are currently on record for CYTOSORBENTS CORPORATION, filed with Delaware Division of Corporations. Management authority at CYTOSORBENTS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does CYTOSORBENTS CORPORATION have a parent company or subsidiaries?
CYTOSORBENTS CORPORATION has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to CYTOSORBENTS CORPORATION's ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to CYTOSORBENTS CORPORATION's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CYTOSORBENTS CORPORATION's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CYTOSORBENTS CORPORATION's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.